| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/08/2006 | EP1631238A2 Antibodies specific for cancer associated antigen sm5-1 and uses thereof |
| 03/08/2006 | EP1438341B1 Antibody stimulating il-1ra production |
| 03/08/2006 | EP1326589B1 Nanoparticles |
| 03/08/2006 | EP1272213B1 Microbial delivery system |
| 03/08/2006 | EP1238086B1 Vaccine for enhancing immune responses to herpes simplex virus |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1220611B1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 03/08/2006 | EP1204744B1 Isolated peptide of the horny layer and use thereof |
| 03/08/2006 | EP1185659B1 Dna pcv vaccine |
| 03/08/2006 | EP1180041B1 Vaccine against isa virus |
| 03/08/2006 | EP1123396B1 Minimal promoters and uses thereof |
| 03/08/2006 | EP1085842B1 Apparatus and methods for preparing an implantable graft |
| 03/08/2006 | EP1032662B1 Methods and compositions for immunomodulation |
| 03/08/2006 | EP0983303B1 Method for the production of non-immunogenic proteins |
| 03/08/2006 | EP0946730B1 Mutants of streptococcal toxin c and methods of use |
| 03/08/2006 | EP0920502B1 Methods and means for modifying complement activation |
| 03/08/2006 | EP0910628B1 Inactivation resistant factor viii |
| 03/08/2006 | EP0841945B1 Cell derived antigen presenting vesicles |
| 03/08/2006 | EP0841941B1 Novel non-pyrogenic bacterial strains and use of the same |
| 03/08/2006 | EP0728015B1 Method of producing a set of combinatorial polypeptide antigens |
| 03/08/2006 | EP0553291B1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 03/08/2006 | CN1745299A Method of diagnosis, treatment and useful agents for conditions characterized by modulation in the level of activin beta c |
| 03/08/2006 | CN1745175A Active immunization to generate antibodies to soluble A-beta |
| 03/08/2006 | CN1745174A Recombinant hepatitis A virus antigens obtained in plant cells |
| 03/08/2006 | CN1745170A High pressure spray-dry of bioactive materials |
| 03/08/2006 | CN1745103A Antibody molecules having specificity for human IL-1 beta |
| 03/08/2006 | CN1745102A Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 03/08/2006 | CN1745101A Antibodies directed to tumor necrosis factor and uses thereof |
| 03/08/2006 | CN1745098A Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 03/08/2006 | CN1745096A Cross-protective epitopes of moraxella catarrhalis and use thereof |
| 03/08/2006 | CN1745095A A method for the production of HIV-1 GAG virus-like particles |
| 03/08/2006 | CN1745094A Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 03/08/2006 | CN1744915A Escape mutants of newcastle disease virus as marker vaccines |
| 03/08/2006 | CN1744912A Stabilized preparation containing protein |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1744883A Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof |
| 03/08/2006 | CN1744822A Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 03/08/2006 | CN1244698C Expression of recombination SARS virus gene in polymorphic Hansen yeast and its use |
| 03/08/2006 | CN1244692C Aujeszkys TK*/gE*/gI* gene dificiency mark live vaccine and preparation method thereof |
| 03/07/2006 | US7009040 Administering a monoclonal antibody encoded by a clone on deposit which binds specifically to an antigen expressed by a tumor; screening for cancerous cells; biological conjugation with a radioisotope, enzyme toxins and hematogenous cells; antitumor agents; anticarcinogenic agents; cytotoxicity |
| 03/07/2006 | US7009037 Modified HIV-1gag p17 peptide and immunogenic composition |
| 03/07/2006 | US7009035 Peptide for use in the diagnosis and treatment of tumors |
| 03/07/2006 | US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008791 Liposome-entrapped DNA oral vaccines |
| 03/07/2006 | US7008790 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| 03/07/2006 | US7008784 prepared from recombinant expression vector comprising heterologous promoter connected to DNA molecule comprising modified HIV genome devoid of long terminal repeat regulatory regions but containing gag ang pol genes in genomic arrangement |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008774 Immunoassay for detecting exposure to leishmania parasites |
| 03/07/2006 | US7008773 Method for identifying active anti apoptosis compounds |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008625 Recombinant constructs of Borrelia burgdorferi |
| 03/07/2006 | US7008624 IL-15 or muteins covalently bound to group (PEG, PVP,PVA, dextran, gelatin) that sterically interferes with signal transduction through IL-15 receptor complex; allograft rejection and graft-versus-host disease |
| 03/07/2006 | US7008623 Antibodies to CD23, derivatives thereof, and their therapeutic uses |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/07/2006 | CA2220048C Acellular pertussis vaccines and methods of preparation thereof |
| 03/02/2006 | WO2006023947A2 A system and method for heightening a humoral immune response |
| 03/02/2006 | WO2006023893A2 Methods for modulating angiogenesis and apoptosis with apelin compositions |
| 03/02/2006 | WO2006023827A2 Methods for treatment of angiogenesis |
| 03/02/2006 | WO2006023791A2 Methods and compositions for treating allergic inflammation |
| 03/02/2006 | WO2006023774A2 Plasma or serum fraction for treatment and prevention of viral infections and related conditions |
| 03/02/2006 | WO2006023649A2 Treatment of severe multiple sclerosis |
| 03/02/2006 | WO2006023420A2 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | WO2006023403A2 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | WO2006023382A2 Collagen vi and cancer |
| 03/02/2006 | WO2006023332A2 Method for the inhibition of angiogenesis or cancer using protective antigen related molecules |
| 03/02/2006 | WO2006022682A2 Method and compositions for treating diseases targeting cd49b |
| 03/02/2006 | WO2006022543A1 Nutricional composition comprising immunoglobulins and oligosaccharides |
| 03/02/2006 | WO2006022542A1 Nutricional composition comprising indigestible oligosaccharides |
| 03/02/2006 | WO2006022422A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 03/02/2006 | WO2006022409A1 Hazardous substance scavenger and application apparatus and application method therefor |
| 03/02/2006 | WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer |
| 03/02/2006 | WO2006022215A1 RECOMBINANT VACCINICA VIRUS DIs STRAIN HOLDING DNA ENCODING SARS-CORONAVIRUS PROTEIN AND UTILIZATION THEREOF |
| 03/02/2006 | WO2006021643A1 Vaccine composition against rhodococcus equi |
| 03/02/2006 | WO2006021210A2 Binding member towards pneumolysin |
| 03/02/2006 | WO2006002193A3 Prrsv subunit vaccines |
| 03/02/2006 | WO2006000740A3 Assay and kits therefor |
| 03/02/2006 | WO2006000448A3 Fc-INTERFERON-BETA FUSION PROTEINS |
| 03/02/2006 | WO2005123777A3 Method of treating granuloma annulare or sarcoid |
| 03/02/2006 | WO2005123123A3 Therapeutic reprogramming, hybrid stem cells and maturation |
| 03/02/2006 | WO2005118886A3 Stable peptide mimetic of hiv gp41 fusion intermediate |
| 03/02/2006 | WO2005110492A3 Method of using adenoviral vectors to induce an immune response |
| 03/02/2006 | WO2005109004A3 Disease related protein aggregation |
| 03/02/2006 | WO2005103073A3 Td antigens |
| 03/02/2006 | WO2005100990A3 Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2) |
| 03/02/2006 | WO2005072088A3 Immunotherapy compositions, method of making and method of use thereof |
| 03/02/2006 | WO2005000351A3 Combination therapy for b cell disorders |
| 03/02/2006 | WO2004092332A3 Sars virus polypeptides |
| 03/02/2006 | WO2004066933A3 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 03/02/2006 | WO2003039232A3 Endothelial cell derived hemotopoietic growth factor |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | US20060047437 System and method for heightening an immune response |
| 03/02/2006 | US20060047436 System and method for magnifying an immune response |
| 03/02/2006 | US20060047435 System and method related to augmenting an immune system |
| 03/02/2006 | US20060047433 System and method related to enhancing an immune system |
| 03/02/2006 | US20060047107 Cortistatin: neuropeptides, compositions and methods |
| 03/02/2006 | US20060046290 Conjugate formed by reacting a first compound with a second compound (particularly biomacromolecules) in which the conjugation involves an electrophilic moiety; deactivation by reacing unreacted electrophilic moieties with a nucleophilic reagent (hydrazine or an alkylenediamine); immunoassay reagents |
| 03/02/2006 | US20060045889 Novel recombinant sabin type 1 poliovirus vector and vaccine against poliovirus |
| 03/02/2006 | US20060045888 Antigen library immunization |
| 03/02/2006 | US20060045886 HIV immunostimulatory compositions |